CORT Daniel N Swisher JR sells $157K worth of shares
May 15, 2025, 4:35 AM
0.00%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
Daniel N Swisher JR sold 2,200 shares of CORT on 12 May at $71.55 per share, worth a total of $157K. They now own 400 CORT shares, or a 100% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
